DARE logo

DARE
Dare Bioscience Inc

25,082
Mkt Cap
$41.35M
Volume
1.47M
52W High
$9.19
52W Low
$1.27
PE Ratio
-2.13
DARE Fundamentals
Price
$2.86
Prev Close
$2.84
Open
$2.88
50D MA
$1.99
Beta
0.43
Avg. Volume
882,044.12
EPS (Annual)
-$1.20
P/B
14.49
Rev/Employee
$42,924.71
$4.92
Loading...
Loading...

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available

Earnings Recap

• Reported GAAP EPS of -$0.20 up 60.00% YoY • Reported revenue of $0.15M up 499.58% YoY • Dare Bioscience expects existing cash and cash equivalents to fund operating needs, including planned DARE to PLAY commercial launch activities, into Q4 2026, though 2026 revenue is uncertain.

Bullish

Dare Bioscience achieved significant revenue growth and a reduced net loss, while advancing its DARE-HPV clinical study and expecting Flora Sync LF5 commercial availability in June 2026.

Bearish

Dare Bioscience faces substantial doubt about its going concern ability due to uncertain revenue generation from new strategies and delays in accessing critical non-dilutive grant funding.

Latest DARE News

View
Top Discussions